BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang Q, Wang X, Jin H, Mi Y, Liu L, Dong M, Chen Y, Zou Z. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies. Eur J Pharm Biopharm 2021;163:60-71. [PMID: 33775853 DOI: 10.1016/j.ejpb.2021.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Perše M. Cisplatin Mouse Models: Treatment, Toxicity and Translatability. Biomedicines 2021;9:1406. [PMID: 34680523 DOI: 10.3390/biomedicines9101406] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ohsawa M, Makino T, Takimoto Y, Inui A. Application of Kampo medicines for the palliation of cancer cachexia. Neuropeptides 2021;90:102188. [PMID: 34488048 DOI: 10.1016/j.npep.2021.102188] [Reference Citation Analysis]
3 Li Z, Yao Q, Tian Y, Jiang Y, Xu M, Wang H, Xiong Y, Fang J, Lu W, Yu D, Shi H. Trehalose protects against cisplatin-induced cochlear hair cell damage by activating TFEB-mediated autophagy. Biochem Pharmacol 2021;:114904. [PMID: 34971589 DOI: 10.1016/j.bcp.2021.114904] [Reference Citation Analysis]
4 Fetoni AR, Paciello F, Troiani D. Cisplatin chemotherapy and cochlear damage: otoprotective and chemosensitization properties of polyphenols. Antioxid Redox Signal 2021. [PMID: 34731023 DOI: 10.1089/ars.2021.0183] [Reference Citation Analysis]